May 4 (Reuters) - Australia's medical centre operator Healius (HLS) on Thursday recommended that its shareholders reject the A$1.52 billion ($1.01 billion) all-share takeover offer by Australian Clinical Labs (ACL) .
The offer, made in March, has "no cash and no premium" and is "plainly inadequate", Healius said in its statement.
($1 = 1.5047 Australian dollars)
News: ACL Australia's Healius rejects $1 bln buyout offer by Australian Clinical Labs
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.83 |
Change
0.000(0.00%) |
Mkt cap ! $555.7M | |||
| Open | High | Low | Value | Volume |
| $2.85 | $2.86 | $2.81 | $4.431M | 1.570M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25431 | $2.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.86 | 11164 | 3 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |